Standing on the Tide, Riding the Waves

Hua Lirong, Chairman of Jiuzhou Pharmaceutical
was honored as one of the
Top Ten “Businessmen of Zhejiang” in 2023

Presentation of Awards by the Organizing Committee

A small molecular chain
Hiding the heart of the world
Helping Innovative Drugs
It is the responsibility to break through the bottleneck
Walking the most dangerous road
Crossing the deepest chasm
We are willing to endure the hardship
The road is full of flowers, and the nine continents are like a blossom.

Zhejiang Businessmen of the Year

On the evening of January 19, the annual grand ceremony of Zhejiang economic sector - 2023 Annual Wind and Cloud Zhejiang Businessmen Award Ceremony was held in Hangzhou. Ten Zhejiang businessmen of the year and one group of Zhejiang businessmen of the year were officially announced. Hua Lirong, Chairman of Jiuzhou Pharmaceuticals, was honored to be the “2023 Fengyun Zhejiang Businessman of the Year”. Yu Hanyin, Deputy Minister of Propaganda Department of Zhejiang Provincial Party Committee and Director of Information Office of Provincial Government, presented the award to Hua Lirong.

Zhejiang Province, the economic sector “Oscar” known as the wind and clouds of Zhejiang businessmen selection, began in 2003, so far has been more than 20 years. To carry forward the spirit of Zhejiang businessmen, promote the development of Zhejiang flag waving, drums and cheering, and become a vivid carrier to publicize the economic and social development of Zhejiang, showing the charm of Zhejiang businessmen, a shining window.

The “Businessmen of Zhejiang” highly affirmed the fruitful achievements made by Jiuzhou Pharmaceuticals under the leadership of Hua Lirong on the way of practicing high-quality development, which was widely recognized by the society. more than 20 years ago, Hua Lirong took over the seal of command from her father, led the enterprise to continuously innovate and upgrade, and accelerated the industrial transformation with the orientation of serving the national strategy, and continued to strengthen the leading power of the industry, which helped China's innovation and development, and made a great contribution to the development of the industry. The guiding force, in helping China's innovative drugs to speed up the process of listing has made outstanding achievements, showing as the Zhejiang businessman figure of the mission of continuous iteration and upgrading, the mission of the youth and blue relay.

Industrial transformation and successful construction of CDMO business model

In 2008, with keen market insight, Hua Lirong was one of the first companies in China to build a one-stop service business model for customized development and manufacturing (CDMO) of innovative drugs, which set a benchmark for the successful transformation of traditional generic API companies into CDMO. Through the global strategic layout, the company's overseas business covers more than 90 countries and regions around the world, with more than 900 global partners.

Deep plowing brand, innovation led layout development high point

Based on Taizhou, Jiuzhou Pharmaceuticals has laid out its global business map, explored domestic and international markets, and developed a “groundnut economy” with strong roots and wide vines, and flourishing leaves. 2010, Hua Lirong led the team to successively build an international standard CDMO plant for innovative drugs in Taizhou, and acquire foreign companies, such as Novartis Suzhou plant, Sandoz Zhongshan plant, and PharmAgra R&D company in the United States. Since 2010, Lirong Hua has led her team to build an international standard innovative drug CDMO plant in Taizhou, acquire Novartis Suzhou plant, Sandoz Zhongshan plant, PharmAgra R&D company in the U.S. and other foreign companies, and build an integrated business of CDMO “API + formulation”.

As an innovative drug customization service enterprise, technological innovation is the driving force for sustainable development. Over the years, Jiuzhou Pharmaceuticals has taken innovation as an engine, and has built industry technology platforms such as chiral catalysis and continuous reaction, and accelerated the layout of innovation platforms such as peptide and coupled drug technology and continuous electrochemical technology. Since 2019, it has organized five consecutive China Innovative Drug Research Summit Forums to guide the industry's technological upgrading and green development.

Practicing responsibility, showing entrepreneurs' sense of responsibility

 Hua Lirong has always been concerned about the public, return to society. 2021, funded the establishment of Taizhou City, the first enterprise fund named “care” - Jiuzhou Pharmaceutical Care Fund, financial support for the poor, students with good character and academic excellence, to help them grow up and become a success; in the poverty alleviation, and Sichuan Ebian, Seda into the East-West poverty alleviation collaboration partners, donations to industrial support to promote the sustainable development of the local economy and society. In terms of poverty alleviation, the company has formed a partnership with Ebian and Seda in Sichuan Province to help alleviate poverty from the East and West, and has donated funds for industrial support to promote the sustainable development of the local economy and society.

Flowers bloom along the way. Flower Lirong with boldness and wisdom, in the fierce market business sea, open up a piece of their own world. She is the outstanding representative of thousands of “Zheshang Power”, an active participant, witness and promoter of the development of innovative drugs in China in the new era. Under her leadership, Jiuzhou Pharmaceuticals is moving towards the vision of becoming “an outstanding life and health enterprise with global drug innovation solutions”. Under her leadership, Jiuzhou Pharmaceuticals is moving towards the vision of becoming “an outstanding life and health enterprise with global drug innovation solutions”, safeguarding human health with high-quality products and services, and heading towards the future. ......

Standing on the Tide, Riding the Waves

Hua Lirong, Chairman of Jiuzhou Pharmaceutical
was honored as one of the
Top Ten “Businessmen of Zhejiang” in 2023

Presentation of Awards by the Organizing Committee

A small molecular chain
Hiding the heart of the world
Helping Innovative Drugs
It is the responsibility to break through the bottleneck
Walking the most dangerous road
Crossing the deepest chasm
We are willing to endure the hardship
The road is full of flowers, and the nine continents are like a blossom.

Zhejiang Businessmen of the Year

On the evening of January 19, the annual grand ceremony of Zhejiang economic sector - 2023 Annual Wind and Cloud Zhejiang Businessmen Award Ceremony was held in Hangzhou. Ten Zhejiang businessmen of the year and one group of Zhejiang businessmen of the year were officially announced. Hua Lirong, Chairman of Jiuzhou Pharmaceuticals, was honored to be the “2023 Fengyun Zhejiang Businessman of the Year”. Yu Hanyin, Deputy Minister of Propaganda Department of Zhejiang Provincial Party Committee and Director of Information Office of Provincial Government, presented the award to Hua Lirong.

Zhejiang Province, the economic sector “Oscar” known as the wind and clouds of Zhejiang businessmen selection, began in 2003, so far has been more than 20 years. To carry forward the spirit of Zhejiang businessmen, promote the development of Zhejiang flag waving, drums and cheering, and become a vivid carrier to publicize the economic and social development of Zhejiang, showing the charm of Zhejiang businessmen, a shining window.

The “Businessmen of Zhejiang” highly affirmed the fruitful achievements made by Jiuzhou Pharmaceuticals under the leadership of Hua Lirong on the way of practicing high-quality development, which was widely recognized by the society. more than 20 years ago, Hua Lirong took over the seal of command from her father, led the enterprise to continuously innovate and upgrade, and accelerated the industrial transformation with the orientation of serving the national strategy, and continued to strengthen the leading power of the industry, which helped China's innovation and development, and made a great contribution to the development of the industry. The guiding force, in helping China's innovative drugs to speed up the process of listing has made outstanding achievements, showing as the Zhejiang businessman figure of the mission of continuous iteration and upgrading, the mission of the youth and blue relay.

Industrial transformation and successful construction of CDMO business model

In 2008, with keen market insight, Hua Lirong was one of the first companies in China to build a one-stop service business model for customized development and manufacturing (CDMO) of innovative drugs, which set a benchmark for the successful transformation of traditional generic API companies into CDMO. Through the global strategic layout, the company's overseas business covers more than 90 countries and regions around the world, with more than 900 global partners.

Deep plowing brand, innovation led layout development high point

Based on Taizhou, Jiuzhou Pharmaceuticals has laid out its global business map, explored domestic and international markets, and developed a “groundnut economy” with strong roots and wide vines, and flourishing leaves. 2010, Hua Lirong led the team to successively build an international standard CDMO plant for innovative drugs in Taizhou, and acquire foreign companies, such as Novartis Suzhou plant, Sandoz Zhongshan plant, and PharmAgra R&D company in the United States. Since 2010, Lirong Hua has led her team to build an international standard innovative drug CDMO plant in Taizhou, acquire Novartis Suzhou plant, Sandoz Zhongshan plant, PharmAgra R&D company in the U.S. and other foreign companies, and build an integrated business of CDMO “API + formulation”.

As an innovative drug customization service enterprise, technological innovation is the driving force for sustainable development. Over the years, Jiuzhou Pharmaceuticals has taken innovation as an engine, and has built industry technology platforms such as chiral catalysis and continuous reaction, and accelerated the layout of innovation platforms such as peptide and coupled drug technology and continuous electrochemical technology. Since 2019, it has organized five consecutive China Innovative Drug Research Summit Forums to guide the industry's technological upgrading and green development.

Practicing responsibility, showing entrepreneurs' sense of responsibility

 Hua Lirong has always been concerned about the public, return to society. 2021, funded the establishment of Taizhou City, the first enterprise fund named “care” - Jiuzhou Pharmaceutical Care Fund, financial support for the poor, students with good character and academic excellence, to help them grow up and become a success; in the poverty alleviation, and Sichuan Ebian, Seda into the East-West poverty alleviation collaboration partners, donations to industrial support to promote the sustainable development of the local economy and society. In terms of poverty alleviation, the company has formed a partnership with Ebian and Seda in Sichuan Province to help alleviate poverty from the East and West, and has donated funds for industrial support to promote the sustainable development of the local economy and society.

Flowers bloom along the way. Flower Lirong with boldness and wisdom, in the fierce market business sea, open up a piece of their own world. She is the outstanding representative of thousands of “Zheshang Power”, an active participant, witness and promoter of the development of innovative drugs in China in the new era. Under her leadership, Jiuzhou Pharmaceuticals is moving towards the vision of becoming “an outstanding life and health enterprise with global drug innovation solutions”. Under her leadership, Jiuzhou Pharmaceuticals is moving towards the vision of becoming “an outstanding life and health enterprise with global drug innovation solutions”, safeguarding human health with high-quality products and services, and heading towards the future. ......

Standing on the Tide, Riding the Waves

Hua Lirong, Chairman of Jiuzhou Pharmaceutical
was honored as one of the
Top Ten “Businessmen of Zhejiang” in 2023

Presentation of Awards by the Organizing Committee

A small molecular chain
Hiding the heart of the world
Helping Innovative Drugs
It is the responsibility to break through the bottleneck
Walking the most dangerous road
Crossing the deepest chasm
We are willing to endure the hardship
The road is full of flowers, and the nine continents are like a blossom.

Zhejiang Businessmen of the Year

On the evening of January 19, the annual grand ceremony of Zhejiang economic sector - 2023 Annual Wind and Cloud Zhejiang Businessmen Award Ceremony was held in Hangzhou. Ten Zhejiang businessmen of the year and one group of Zhejiang businessmen of the year were officially announced. Hua Lirong, Chairman of Jiuzhou Pharmaceuticals, was honored to be the “2023 Fengyun Zhejiang Businessman of the Year”. Yu Hanyin, Deputy Minister of Propaganda Department of Zhejiang Provincial Party Committee and Director of Information Office of Provincial Government, presented the award to Hua Lirong.

Zhejiang Province, the economic sector “Oscar” known as the wind and clouds of Zhejiang businessmen selection, began in 2003, so far has been more than 20 years. To carry forward the spirit of Zhejiang businessmen, promote the development of Zhejiang flag waving, drums and cheering, and become a vivid carrier to publicize the economic and social development of Zhejiang, showing the charm of Zhejiang businessmen, a shining window.

The “Businessmen of Zhejiang” highly affirmed the fruitful achievements made by Jiuzhou Pharmaceuticals under the leadership of Hua Lirong on the way of practicing high-quality development, which was widely recognized by the society. more than 20 years ago, Hua Lirong took over the seal of command from her father, led the enterprise to continuously innovate and upgrade, and accelerated the industrial transformation with the orientation of serving the national strategy, and continued to strengthen the leading power of the industry, which helped China's innovation and development, and made a great contribution to the development of the industry. The guiding force, in helping China's innovative drugs to speed up the process of listing has made outstanding achievements, showing as the Zhejiang businessman figure of the mission of continuous iteration and upgrading, the mission of the youth and blue relay.

Industrial transformation and successful construction of CDMO business model

In 2008, with keen market insight, Hua Lirong was one of the first companies in China to build a one-stop service business model for customized development and manufacturing (CDMO) of innovative drugs, which set a benchmark for the successful transformation of traditional generic API companies into CDMO. Through the global strategic layout, the company's overseas business covers more than 90 countries and regions around the world, with more than 900 global partners.

Deep plowing brand, innovation led layout development high point

Based on Taizhou, Jiuzhou Pharmaceuticals has laid out its global business map, explored domestic and international markets, and developed a “groundnut economy” with strong roots and wide vines, and flourishing leaves. 2010, Hua Lirong led the team to successively build an international standard CDMO plant for innovative drugs in Taizhou, and acquire foreign companies, such as Novartis Suzhou plant, Sandoz Zhongshan plant, and PharmAgra R&D company in the United States. Since 2010, Lirong Hua has led her team to build an international standard innovative drug CDMO plant in Taizhou, acquire Novartis Suzhou plant, Sandoz Zhongshan plant, PharmAgra R&D company in the U.S. and other foreign companies, and build an integrated business of CDMO “API + formulation”.

As an innovative drug customization service enterprise, technological innovation is the driving force for sustainable development. Over the years, Jiuzhou Pharmaceuticals has taken innovation as an engine, and has built industry technology platforms such as chiral catalysis and continuous reaction, and accelerated the layout of innovation platforms such as peptide and coupled drug technology and continuous electrochemical technology. Since 2019, it has organized five consecutive China Innovative Drug Research Summit Forums to guide the industry's technological upgrading and green development.

Practicing responsibility, showing entrepreneurs' sense of responsibility

 Hua Lirong has always been concerned about the public, return to society. 2021, funded the establishment of Taizhou City, the first enterprise fund named “care” - Jiuzhou Pharmaceutical Care Fund, financial support for the poor, students with good character and academic excellence, to help them grow up and become a success; in the poverty alleviation, and Sichuan Ebian, Seda into the East-West poverty alleviation collaboration partners, donations to industrial support to promote the sustainable development of the local economy and society. In terms of poverty alleviation, the company has formed a partnership with Ebian and Seda in Sichuan Province to help alleviate poverty from the East and West, and has donated funds for industrial support to promote the sustainable development of the local economy and society.

Flowers bloom along the way. Flower Lirong with boldness and wisdom, in the fierce market business sea, open up a piece of their own world. She is the outstanding representative of thousands of “Zheshang Power”, an active participant, witness and promoter of the development of innovative drugs in China in the new era. Under her leadership, Jiuzhou Pharmaceuticals is moving towards the vision of becoming “an outstanding life and health enterprise with global drug innovation solutions”. Under her leadership, Jiuzhou Pharmaceuticals is moving towards the vision of becoming “an outstanding life and health enterprise with global drug innovation solutions”, safeguarding human health with high-quality products and services, and heading towards the future. ......